Thyroid autoimmunity does not delineate a cardiometabolic or androgenic phenotype in women with polycystic ovary syndrome: a pre-specified cross-sectional analysis - Takeaways - MDSpire

Thyroid autoimmunity does not delineate a cardiometabolic or androgenic phenotype in women with polycystic ovary syndrome: a pre-specified cross-sectional analysis

  • By

  • Natalia Piórkowska

  • Lech Madeyski

  • Marcin Leśniewski

  • Grzegorz Franik

  • Anna Bizoń

  • May 1, 2026

  • 0 min

Share

  • 1

    Thyroid autoimmunity was not associated with a more severe cardiometabolic or androgenic phenotype in women with polycystic ovary syndrome.

  • 2

    The study analyzed 1,300 women with PCOS using predefined criteria for thyroid autoimmunity and various cardiometabolic outcomes.

  • 3

    No significant links were found between thyroid autoimmunity and primary or secondary cardiometabolic outcomes in the cohort.

  • 4

    Exploratory analyses indicated differences in thyroid-stimulating hormone levels, but no significant androgenic variables after correction.

  • 5

    The findings suggest that anti-TPO positivity does not identify a high-risk metabolic subgroup among women with PCOS.

Original Source(s)

Thyroid autoimmunity does not delineate a cardiometabolic or androgenic phenotype in women with polycystic ovary syndrome: a pre-specified cross-sectional analysis

  • by Natalia Piórkowska, Lech Madeyski, Marcin Leśniewski, Grzegorz Franik, Anna Bizoń

  • May 1, 2026

Related Content

Follicular fluid proteomic alterations associated with oocyte developmental potential in polycystic ovary syndrome

Diabetes Risk Scores: Beyond Glucose

Multi-ancestry polygenic models identify high-risk patients traditional screening may miss.

PCOS Renamed PMOS After Global Consensus

International initiative reframes a common endocrine disorder around its metabolic and ovarian features rather than ovarian cysts